Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The XPAND Evaluation of a Personalised Adherence Intervention to Improve Photoprotection Behaviour in Adults With Xeroderma Pigmentosum (XP): Randomised Controlled Trial.

NCT03445052 is registered in ClinicalTrials.gov with Guy's and St Thomas' NHS Foundation Trust as lead sponsor.

NCT NCT03445052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03445052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The XPAND Evaluation of a Personalised Adherence Intervention to Improve Photoprotection Behaviour in Adults With Xeroderma Pigmentosum (XP): Randomised Controlled Trial.
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
March 30, 2018
Completion date
January 30, 2020
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

xeroderma pigmentosum